On May 17, 2023, San Francisco City Attorney David Chiu announced Walgreens agreed to pay the People of San Francisco $230 million for its role…
Read MorePast Results: Drugs & Devices
Category: Drugs & Devices
A $230 Million Opioid Settlement with Walgreens Reached for San Francisco Represented by W&L and Co-Counsel
On May 17, 2023, San Francisco City Attorney David Chiu announced Walgreens agreed to pay the People of San Francisco $230 million for its…
Category: Consumer, Drugs & Devices
W&L and Co-Counsel Reach $235M Settlement in Altria E-Cig Youth Vaping Crisis
Weitz & Luxenberg and co-lead counsel are pleased to announce a historic $235 million settlement with defendant Altria Group, Inc., in the federal multidistrict…
Category: Consumer, Drugs & Devices
Plaintiffs’ Co-Lead Counsel Announce Four Major Settlements with JUUL Labs, Inc. Addressing U.S. Youth E-Cigarette Usage
The four settlements with JUUL Labs announced on December 6 resolve the personal injury, consumer class action, government entity, and tribal harm cases brought…
Category: Drugs & Devices
Resolution Reached in Stryker Hips Lawsuit
On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABGII modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. The settlement was finalized after four months of negotiations before retired United States Magistrate Judge Diane Welsh of JAMS in Philadelphia. Stryker…
Category: Drugs & Devices
$2.5 Billion in DePuy Hip Settlement
Thousands of patients whose hip implants failed and were removed prior to August 31, 2013 and who enrolled in the $2.5 billion settlement will begin to receive their settlement payments. Late last week, DePuy and its parent company Johnson & Johnson agreed to waive its ”walk-away rights” and are proceeding to fund the six-figure settlements…